Portfolio Scan: How Sequoia, A91-backed drugmaker La Renon is bouncing back

 Portfolio Scan: How Sequoia, A91-backed drugmaker La Renon is bouncing back
Sequoia Capital-backed drugmaker La Renon Healthcare Pvt Ltd is back on a high double-digit growth path in the current fiscal year that would help it move well past its pre-pandemic revenue. The company, which also counts growth equity investor A91 Partners as a backer, had taken a hit on its […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.

Vivek Sinha

error: Content is protected !!
The Capital Quest